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Summary Although very late stent thrombosis after drug-eluting stent implantation is a crit-
ical event, its cause has not been clariﬁed. This is the ﬁrst report of a case with very late
stent thrombosis after drug-eluting stent implantation for which prior angioscopic image of the
culprit lesion is available.
A 54-year-old Japanese male patient with stable angina who received implantation of
sirolimus-eluting stent at the culprit lesion and 1-year follow-up angiographic and angioscopic
examinations came back with chest pain at rest at 2.5 years after the stent implantation.
Very late stent thrombosis was diagnosed by emergent angiographic and angioscopic exami-
nations and was treated by zotarolimus-eluting stent. One-year angiographic and angioscopic
follow-up examinations after zotarolimus-eluting stent were performed. Angioscopy revealed
uncovered stent strut, yellow plaques, and thrombus at 1-year follow-up after sirolimus-eluting
stent implantation, and it conﬁrmed the thrombotic occlusion inside the sirolimus-eluting stent
at the time of emergent catheterization.
This is a case of very late stent thrombosis in the drug-eluting stent where uncovered stent
strut, yellow plaques, and thrombus had been detected by angioscopy 1.5 years before the
souronset. Those thrombogenic
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ntroductionrug-eluting stents (DES) dramatically reduced restenosis
ompared with bare metal stents (BMS). However, it was
hocking that stent thrombosis (ST) increased at the contin-
ous rate of 0.6% per year. Although the incidence of ST is
Published by Elsevier Ltd. All rights reserved.
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Figure 1 Angiographic and angioscopic images at 1-year follow-up after sirolimus-eluting stent implantation. A 54-year-old
Japanese male patient with stable angina who received implantation of sirolimus-eluting stent at the chronic total occlusion lesion
in the mid left anterior descending artery received 1-year follow-up examinations. Peri-stent staining was detected by angiography.
Yellow plaques, uncovered stent strut, and thrombus were detected at the stented lesion by angioscopy. Yellow plaques were present
both inside the stented lesion and its proximal segment. They were accompanied by the mural red and white (mixed) thrombus
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tadhesion. The stent struts were mainly covered by the thin lay
with its metallic glistening. The malapposition of stent struts w
very rare, it is critical once it has occurred. ST is supposed
to be caused by various factors such as cessation of dual
antiplatelet therapy (DAPT), stent incomplete apposition,
and inadequate formation of neointima. On the other hand,
the direct cause of thrombus formation [1] is supposed to
be an exposed stent metal or disrupted yellow plaques that
are also a cause of acute coronary syndrome (ACS). Yellow
plaques have been associated with vulnerable plaques and
high thrombogenic potential [2]. Furthermore, the future
risk of ACS events has been associated with the number of
yellow plaques in a coronary vessel [3]. Those disrupted yel-
low plaques, exposed stent, and thrombus can be detected
by angioscopic examination. Therefore, those angioscopic
ﬁndings might be predictors of ST.
We experienced a patient with very late ST (VLST) at
2.5 years after DES implantation in whom angiographic and
angioscopic examinations had been performed at one year
after implantation. Furthermore, the VLST was treated by
a different type of DES and angiographic and angioscopic
one-year follow-up was again performed, which revealed
different healing response of neointima formation in the
same patient after the ﬁrst and the second DES implanta-
tion. This is the ﬁrst report of a DES VLST case in which
prior angioscopic images of the lesion are available.
a
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lneointima and/or white thrombus but were partly uncovered
t detected by angioscopy.
ase report
54-year-old Japanese male patient with stable angina
eceived percutaneous coronary intervention (PCI) and
mplantation of sirolimus-eluting stent (SES) at the chronic
otal occlusion lesion in the mid left anterior descending
rtery. One-year follow up was performed with angiographic
nd angioscopic examinations (Fig. 1). Peri-stent stain-
ng was detected by angiography. Yellow plaques, exposed
tent, and thrombus were detected at the stented lesion by
ngioscopy.
He came back with chest pain at rest 1.5 years
ater, which was 2.5 years after the implantation of the
ES. Although no abnormality in electrocardiography was
bserved, the elevation of serum troponin T was detected.
e performed emergent catheterization and found coronary
cclusion at the stented lesion by angiography. After throm-
us aspiration, we performed angioscopic examination and
ound thrombus directly adhering to the vessel wall inside
he stented lesion, which could conﬁrm this event as VLST
nd deny the possibility of new lesion ACS event outside
ut adjacent to the stent that could not be differentiated
y angiography alone (Fig. 2). We performed PCI at the
esion again and implanted a zotarolimus-eluting stent (ZES)
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Figure 2 Angiographic and angioscopic images at very late stent thrombosis. The patient came back with chest pain at rest 1.5
years after the follow-up examination, which was 2.5 years after the sirolimus-eluting stent implantation. Emergent catheterization
revealed occlusion of mid left anterior descending artery at the stented site. Angioscopy performed immediately after thrombo-
aspiration conﬁrmed the thrombotic occlusion inside the stented lesion where yellow plaques, uncovered stent strut, and thrombus
were detected at 1-year follow-up. Acute coronary syndrome due to new plaque rupture outside the stent was denied by the
angioscopic examination. Coronary artery was initially occluded at the site of the red arrow. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of the article.)
Figure 3 Angiographic and angioscopic images at 1-year follow-up after zotarolimus-eluting stent (ZES) implantation for very late
stent thrombosis (VLST). At the time of VLST, ZES was implanted at the culprit lesion after thrombus aspiration. One-year follow-up
examination revealed no restenosis or peri-stent staining by angiography. Stent strut and yellow plaques were generally covered by
white smooth neointima, and thrombus was not detected in the stented lesion.
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[Very late stent thrombosis at 2.5 years after sirolimus-elutin
expecting better neointima formation. At one-year follow-
up after ZES implantation, we found white smooth neointima
that covered stents and yellow plaques without thrombus
formation on it (Fig. 3), which was similar to the appear-
ance after BMS implantation. DAPT was continued for this
patient throughout the period.
Discussion
We have experienced a case of VLST in which prior angio-
scopic images of the lesion are available. Angioscopically-
detected exposed stent, yellow plaques, and/or thrombus
formation detected at one-year follow-upmight have caused
the VLST. Possible sources of thrombogenicity that might
cause VLST have been proposed: (1) stent struts that failed
to be covered by neointima; (2) disrupted yellow plaques
that failed to be covered by neointima; and/or (3) new
disruption of yellow plaques that might be formed as a nat-
ural course of atherosclerosis progression or promoted by
DES. Our observation has been consistent with the previous
reports [4,5] that neointima coverage is better and throm-
bus and yellow plaque are less frequently detected after
the implantation of ZES than after the implantation of SES.
Thrombus has been detected in 10—40% vs. 10% of cases with
sirolimus vs. zotarolimus stent implantation at 6—18 months
follow-up, respectively. Thrombus has been detected more
frequently on the yellow than on the white vessel area (25%
vs. 5%) in SES at 10 months’ follow-up. SES promote the for-
mation of yellow plaques at the stent-implanted segments.
Now, we routinely perform one-year follow-up angio-
scopic examination after DES implantation to evaluate
neointima coverage of stent, yellow plaque, and thrombus
in DESNOTE (Detect the Event of late Stent thrombosis from
the drug-eluting stent NOT well covered by nEointima deter-
mined by angioscopy) trial. We may be able to clarify the
[ent implantation e15
rue risks of VLST by this trial, and then, classify patients
nto low- or high-risk patients of VLST. DAPT may possibly
e discontinued safely in the low-risk patients, while much
tronger antiplatelet therapy might be required for the high-
isk patients.
onclusion
e reported, for the ﬁrst time, a case of DES VLST in which
rior angioscopic images of the culprit lesion were available.
lthough we have no established markers for the risk strat-
ﬁcation of VLST, angioscopic ﬁndings at one-year follow-up
ay reﬂect the risk. Further investigations are expected.
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